Effects of scoparone on dopamine release in PC12 cells

Fitoterapia. 2010 Sep;81(6):497-502. doi: 10.1016/j.fitote.2010.01.003. Epub 2010 Jan 18.

Abstract

The effects of scoparone on dopamine release in PC12 cells were investigated. Scoparone at 50-200 microM increased dopamine release into the culture medium. However, the released levels of dopamine by scoparone were not altered in the absence of extracellular Ca(2+) and by adenylyl cyclase inhibitor MDL-12,330A. Scoparone increased phosphorylation of PKA, CaMK II and synapsin I. Scoparone also enhanced K(+)-induced levels of dopamine release by CaMK II phosphorylation. These results suggest that scoparone increases dopamine release by synapsin I phosphorylation via activation of PKA and CaMK II, which are mediated by cyclic AMP levels and Ca(2+) influx.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenylyl Cyclase Inhibitors
  • Animals
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism
  • Coumarins / pharmacology*
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Dopamine / metabolism*
  • Drug Evaluation, Preclinical
  • Imines / pharmacology
  • PC12 Cells
  • Phosphorylation / drug effects
  • Potassium / metabolism
  • Rats
  • Synapsins / metabolism
  • Vasodilator Agents / pharmacology*

Substances

  • Adenylyl Cyclase Inhibitors
  • Coumarins
  • Imines
  • Synapsins
  • Vasodilator Agents
  • RMI 12330A
  • Cyclic AMP-Dependent Protein Kinases
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • scoparone
  • Potassium
  • Dopamine